title: Dose escalation for GBM in the temozolamide era: in regard to Badiyan et al.
authors: Cadence Brain Tumor Center and CDH Proton Center, Warrenville, Illinois.
authors: Vinai
authors: V
authors: Gondi
authors: University of Maryland School of Medicine, Baltimore, Maryland.
authors: Minesh P
authors: MP
authors: Mehta
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D003606:Dacarbazine / Q000031:analogs & derivatives*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine